nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP2E1—liver cancer	0.151	0.394	CbGaD
Diclofenac—CYP1A1—liver cancer	0.149	0.389	CbGaD
Diclofenac—ALB—liver cancer	0.083	0.217	CbGaD
Diclofenac—UGT2B7—Epirubicin—liver cancer	0.0717	0.192	CbGbCtD
Diclofenac—ABCC4—Sorafenib—liver cancer	0.0555	0.149	CbGbCtD
Diclofenac—UGT1A1—Sorafenib—liver cancer	0.0543	0.145	CbGbCtD
Diclofenac—ABCC1—Epirubicin—liver cancer	0.0509	0.136	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—liver cancer	0.0271	0.0725	CbGbCtD
Diclofenac—CYP2B6—Sorafenib—liver cancer	0.021	0.0562	CbGbCtD
Diclofenac—CYP2C8—Sorafenib—liver cancer	0.0159	0.0426	CbGbCtD
Diclofenac—CYP2C19—Sorafenib—liver cancer	0.0133	0.0357	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—liver cancer	0.0127	0.0341	CbGbCtD
Diclofenac—CYP1A2—Sorafenib—liver cancer	0.0123	0.033	CbGbCtD
Diclofenac—CYP2C9—Sorafenib—liver cancer	0.0111	0.0297	CbGbCtD
Diclofenac—ABCB1—Sorafenib—liver cancer	0.0108	0.0288	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—liver cancer	0.00653	0.0175	CbGbCtD
Diclofenac—CYP3A4—Sorafenib—liver cancer	0.00645	0.0173	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—liver cancer	0.00391	0.0105	CbGbCtD
Diclofenac—Pancreatitis—Epirubicin—liver cancer	0.00013	0.00111	CcSEcCtD
Diclofenac—Vomiting—Sorafenib—liver cancer	0.00013	0.00111	CcSEcCtD
Diclofenac—Abdominal pain upper—Doxorubicin—liver cancer	0.00013	0.00111	CcSEcCtD
Diclofenac—Angina pectoris—Epirubicin—liver cancer	0.000129	0.0011	CcSEcCtD
Diclofenac—Rash—Sorafenib—liver cancer	0.000129	0.0011	CcSEcCtD
Diclofenac—Dermatitis—Sorafenib—liver cancer	0.000129	0.0011	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000128	0.00109	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000128	0.00109	CcSEcCtD
Diclofenac—Headache—Sorafenib—liver cancer	0.000128	0.00109	CcSEcCtD
Diclofenac—Bronchitis—Epirubicin—liver cancer	0.000128	0.00109	CcSEcCtD
Diclofenac—Nasopharyngitis—Doxorubicin—liver cancer	0.000127	0.00108	CcSEcCtD
Diclofenac—Pancytopenia—Epirubicin—liver cancer	0.000126	0.00107	CcSEcCtD
Diclofenac—Gastritis—Doxorubicin—liver cancer	0.000126	0.00107	CcSEcCtD
Diclofenac—Muscular weakness—Doxorubicin—liver cancer	0.000125	0.00107	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000125	0.00107	CcSEcCtD
Diclofenac—Dysuria—Epirubicin—liver cancer	0.000124	0.00106	CcSEcCtD
Diclofenac—Abdominal distension—Doxorubicin—liver cancer	0.000124	0.00105	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Epirubicin—liver cancer	0.000123	0.00105	CcSEcCtD
Diclofenac—Asthma—Doxorubicin—liver cancer	0.000123	0.00105	CcSEcCtD
Diclofenac—Influenza—Doxorubicin—liver cancer	0.000123	0.00105	CcSEcCtD
Diclofenac—Pollakiuria—Epirubicin—liver cancer	0.000123	0.00105	CcSEcCtD
Diclofenac—Eosinophilia—Doxorubicin—liver cancer	0.000122	0.00104	CcSEcCtD
Diclofenac—Nausea—Sorafenib—liver cancer	0.000121	0.00103	CcSEcCtD
Diclofenac—Photosensitivity reaction—Epirubicin—liver cancer	0.000121	0.00103	CcSEcCtD
Diclofenac—Weight increased—Epirubicin—liver cancer	0.000121	0.00103	CcSEcCtD
Diclofenac—Pancreatitis—Doxorubicin—liver cancer	0.00012	0.00103	CcSEcCtD
Diclofenac—Weight decreased—Epirubicin—liver cancer	0.00012	0.00102	CcSEcCtD
Diclofenac—Hyperglycaemia—Epirubicin—liver cancer	0.00012	0.00102	CcSEcCtD
Diclofenac—Angina pectoris—Doxorubicin—liver cancer	0.00012	0.00102	CcSEcCtD
Diclofenac—Pneumonia—Epirubicin—liver cancer	0.000119	0.00101	CcSEcCtD
Diclofenac—Infestation—Epirubicin—liver cancer	0.000118	0.00101	CcSEcCtD
Diclofenac—Drowsiness—Epirubicin—liver cancer	0.000118	0.00101	CcSEcCtD
Diclofenac—Infestation NOS—Epirubicin—liver cancer	0.000118	0.00101	CcSEcCtD
Diclofenac—Bronchitis—Doxorubicin—liver cancer	0.000118	0.00101	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000117	0.001	CcSEcCtD
Diclofenac—Pancytopenia—Doxorubicin—liver cancer	0.000117	0.000994	CcSEcCtD
Diclofenac—Renal failure—Epirubicin—liver cancer	0.000116	0.000992	CcSEcCtD
Diclofenac—Neuropathy peripheral—Epirubicin—liver cancer	0.000116	0.000989	CcSEcCtD
Diclofenac—Stomatitis—Epirubicin—liver cancer	0.000115	0.000983	CcSEcCtD
Diclofenac—Jaundice—Epirubicin—liver cancer	0.000115	0.000983	CcSEcCtD
Diclofenac—Conjunctivitis—Epirubicin—liver cancer	0.000115	0.000981	CcSEcCtD
Diclofenac—Urinary tract infection—Epirubicin—liver cancer	0.000115	0.000981	CcSEcCtD
Diclofenac—Dysuria—Doxorubicin—liver cancer	0.000115	0.000979	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000114	0.000973	CcSEcCtD
Diclofenac—Sweating—Epirubicin—liver cancer	0.000113	0.000967	CcSEcCtD
Diclofenac—Pollakiuria—Doxorubicin—liver cancer	0.000113	0.000967	CcSEcCtD
Diclofenac—Haematuria—Epirubicin—liver cancer	0.000113	0.000962	CcSEcCtD
Diclofenac—Photosensitivity reaction—Doxorubicin—liver cancer	0.000112	0.000956	CcSEcCtD
Diclofenac—Hepatobiliary disease—Epirubicin—liver cancer	0.000112	0.000954	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—liver cancer	0.000112	0.000953	CcSEcCtD
Diclofenac—Epistaxis—Epirubicin—liver cancer	0.000112	0.000952	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—liver cancer	0.000111	0.000947	CcSEcCtD
Diclofenac—Sinusitis—Epirubicin—liver cancer	0.000111	0.000946	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—liver cancer	0.000111	0.000944	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—liver cancer	0.00011	0.000941	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—liver cancer	0.00011	0.000939	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—liver cancer	0.00011	0.000933	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—liver cancer	0.00011	0.000933	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—liver cancer	0.00011	0.000933	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000109	0.000925	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—liver cancer	0.000108	0.000922	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—liver cancer	0.000108	0.000918	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—liver cancer	0.000107	0.000915	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—liver cancer	0.000107	0.00091	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—liver cancer	0.000107	0.00091	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—liver cancer	0.000107	0.00091	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—liver cancer	0.000107	0.000908	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—liver cancer	0.000106	0.000907	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—liver cancer	0.000106	0.000907	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—liver cancer	0.000106	0.000906	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—liver cancer	0.000106	0.000906	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—liver cancer	0.000106	0.000901	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—liver cancer	0.000105	0.000899	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—liver cancer	0.000105	0.000895	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—liver cancer	0.000105	0.000894	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—liver cancer	0.000105	0.000892	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—liver cancer	0.000104	0.00089	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—liver cancer	0.000104	0.000888	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—liver cancer	0.000104	0.000883	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—liver cancer	0.000103	0.00088	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—liver cancer	0.000103	0.000876	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—liver cancer	0.000102	0.000873	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—liver cancer	0.000102	0.000871	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—liver cancer	0.0001	0.000856	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—liver cancer	0.0001	0.000853	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—liver cancer	9.93e-05	0.000846	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—liver cancer	9.91e-05	0.000844	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—liver cancer	9.88e-05	0.000842	CcSEcCtD
Diclofenac—Flushing—Epirubicin—liver cancer	9.86e-05	0.00084	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—liver cancer	9.86e-05	0.00084	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—liver cancer	9.86e-05	0.00084	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—liver cancer	9.83e-05	0.000838	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—liver cancer	9.83e-05	0.000838	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—liver cancer	9.78e-05	0.000834	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—liver cancer	9.76e-05	0.000832	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—liver cancer	9.71e-05	0.000828	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—liver cancer	9.69e-05	0.000825	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—liver cancer	9.64e-05	0.000822	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—liver cancer	9.64e-05	0.000821	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—liver cancer	9.6e-05	0.000818	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—liver cancer	9.58e-05	0.000816	CcSEcCtD
Diclofenac—Chills—Epirubicin—liver cancer	9.53e-05	0.000813	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—liver cancer	9.49e-05	0.000809	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—liver cancer	9.48e-05	0.000808	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—liver cancer	9.39e-05	0.0008	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—liver cancer	9.31e-05	0.000793	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—liver cancer	9.3e-05	0.000792	CcSEcCtD
Diclofenac—Erythema—Epirubicin—liver cancer	9.25e-05	0.000788	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—liver cancer	9.25e-05	0.000788	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—liver cancer	9.19e-05	0.000783	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—liver cancer	9.17e-05	0.000781	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—liver cancer	9.13e-05	0.000778	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—liver cancer	9.13e-05	0.000778	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—liver cancer	9.12e-05	0.000777	CcSEcCtD
Diclofenac—Tension—Epirubicin—liver cancer	9.08e-05	0.000774	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—liver cancer	9.06e-05	0.000772	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—liver cancer	8.98e-05	0.000766	CcSEcCtD
Diclofenac—Back pain—Epirubicin—liver cancer	8.95e-05	0.000763	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—liver cancer	8.92e-05	0.00076	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—liver cancer	8.89e-05	0.000758	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—liver cancer	8.88e-05	0.000757	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—liver cancer	8.86e-05	0.000755	CcSEcCtD
Diclofenac—Chills—Doxorubicin—liver cancer	8.82e-05	0.000752	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—liver cancer	8.78e-05	0.000749	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—liver cancer	8.72e-05	0.000743	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—liver cancer	8.69e-05	0.00074	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—liver cancer	8.61e-05	0.000734	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—liver cancer	8.58e-05	0.000731	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—liver cancer	8.56e-05	0.000729	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—liver cancer	8.56e-05	0.000729	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—liver cancer	8.55e-05	0.000729	CcSEcCtD
Diclofenac—Agitation—Epirubicin—liver cancer	8.5e-05	0.000724	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—liver cancer	8.43e-05	0.000719	CcSEcCtD
Diclofenac—Tension—Doxorubicin—liver cancer	8.4e-05	0.000716	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—liver cancer	8.38e-05	0.000714	CcSEcCtD
Diclofenac—Malaise—Epirubicin—liver cancer	8.34e-05	0.000711	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—liver cancer	8.31e-05	0.000708	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—liver cancer	8.31e-05	0.000708	CcSEcCtD
Diclofenac—Syncope—Epirubicin—liver cancer	8.3e-05	0.000707	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—liver cancer	8.28e-05	0.000706	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—liver cancer	8.28e-05	0.000706	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—liver cancer	8.23e-05	0.000701	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—liver cancer	8.17e-05	0.000697	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—liver cancer	8.13e-05	0.000693	CcSEcCtD
Diclofenac—Cough—Epirubicin—liver cancer	8.07e-05	0.000688	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—liver cancer	8.07e-05	0.000687	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—liver cancer	8.01e-05	0.000683	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—liver cancer	7.99e-05	0.000681	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—liver cancer	7.94e-05	0.000677	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—liver cancer	7.91e-05	0.000674	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—liver cancer	7.88e-05	0.000671	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—liver cancer	7.88e-05	0.000671	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—liver cancer	7.88e-05	0.000671	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—liver cancer	7.87e-05	0.00067	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—liver cancer	7.85e-05	0.000669	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	7.82e-05	0.000667	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—liver cancer	7.78e-05	0.000663	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—liver cancer	7.72e-05	0.000658	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—liver cancer	7.7e-05	0.000656	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—liver cancer	7.69e-05	0.000655	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—liver cancer	7.68e-05	0.000654	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—liver cancer	7.66e-05	0.000653	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—liver cancer	7.61e-05	0.000649	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—liver cancer	7.56e-05	0.000645	CcSEcCtD
Diclofenac—Oedema—Epirubicin—liver cancer	7.55e-05	0.000643	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—liver cancer	7.55e-05	0.000643	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—liver cancer	7.52e-05	0.000641	CcSEcCtD
Diclofenac—Infection—Epirubicin—liver cancer	7.5e-05	0.000639	CcSEcCtD
Diclofenac—Cough—Doxorubicin—liver cancer	7.47e-05	0.000637	CcSEcCtD
Diclofenac—Shock—Epirubicin—liver cancer	7.43e-05	0.000633	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—liver cancer	7.42e-05	0.000632	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—liver cancer	7.4e-05	0.000631	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—liver cancer	7.39e-05	0.00063	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—liver cancer	7.39e-05	0.00063	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—liver cancer	7.37e-05	0.000628	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—liver cancer	7.33e-05	0.000625	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—liver cancer	7.3e-05	0.000622	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—liver cancer	7.29e-05	0.000621	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—liver cancer	7.29e-05	0.000621	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—liver cancer	7.29e-05	0.000621	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—liver cancer	7.26e-05	0.000619	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.24e-05	0.000617	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—liver cancer	7.2e-05	0.000614	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—liver cancer	7.2e-05	0.000613	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—liver cancer	7.13e-05	0.000607	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—liver cancer	7.05e-05	0.000601	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—liver cancer	7.04e-05	0.0006	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—liver cancer	6.99e-05	0.000595	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—liver cancer	6.99e-05	0.000595	CcSEcCtD
Diclofenac—Infection—Doxorubicin—liver cancer	6.94e-05	0.000591	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—liver cancer	6.88e-05	0.000586	CcSEcCtD
Diclofenac—Shock—Doxorubicin—liver cancer	6.87e-05	0.000586	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—liver cancer	6.85e-05	0.000584	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—liver cancer	6.84e-05	0.000583	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—liver cancer	6.83e-05	0.000582	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—liver cancer	6.82e-05	0.000581	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—liver cancer	6.79e-05	0.000578	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—liver cancer	6.78e-05	0.000578	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—liver cancer	6.75e-05	0.000576	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—liver cancer	6.73e-05	0.000574	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—liver cancer	6.71e-05	0.000572	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—liver cancer	6.66e-05	0.000567	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—liver cancer	6.65e-05	0.000566	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—liver cancer	6.56e-05	0.000559	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—liver cancer	6.53e-05	0.000556	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—liver cancer	6.52e-05	0.000555	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—liver cancer	6.51e-05	0.000555	CcSEcCtD
Diclofenac—Constipation—Epirubicin—liver cancer	6.46e-05	0.00055	CcSEcCtD
Diclofenac—Pain—Epirubicin—liver cancer	6.46e-05	0.00055	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.36e-05	0.000542	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—liver cancer	6.32e-05	0.000538	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—liver cancer	6.27e-05	0.000535	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—liver cancer	6.23e-05	0.000531	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—liver cancer	6.22e-05	0.00053	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—liver cancer	6.21e-05	0.000529	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—liver cancer	6.17e-05	0.000526	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—liver cancer	6.15e-05	0.000524	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—liver cancer	6.07e-05	0.000518	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—liver cancer	6.03e-05	0.000514	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—liver cancer	6.02e-05	0.000513	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—liver cancer	6e-05	0.000511	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—liver cancer	5.97e-05	0.000509	CcSEcCtD
Diclofenac—Pain—Doxorubicin—liver cancer	5.97e-05	0.000509	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—liver cancer	5.97e-05	0.000509	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—liver cancer	5.97e-05	0.000509	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—liver cancer	5.76e-05	0.000491	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—liver cancer	5.71e-05	0.000487	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—liver cancer	5.56e-05	0.000474	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—liver cancer	5.55e-05	0.000473	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—liver cancer	5.52e-05	0.000471	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—liver cancer	5.52e-05	0.000471	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—liver cancer	5.42e-05	0.000462	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—liver cancer	5.34e-05	0.000455	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—liver cancer	5.17e-05	0.00044	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—liver cancer	5.15e-05	0.000439	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—liver cancer	5.01e-05	0.000427	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—liver cancer	4.99e-05	0.000425	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—liver cancer	4.94e-05	0.000421	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—liver cancer	4.8e-05	0.000409	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—liver cancer	4.78e-05	0.000407	CcSEcCtD
Diclofenac—Rash—Epirubicin—liver cancer	4.76e-05	0.000406	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—liver cancer	4.76e-05	0.000405	CcSEcCtD
Diclofenac—Headache—Epirubicin—liver cancer	4.73e-05	0.000403	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—liver cancer	4.62e-05	0.000394	CcSEcCtD
Diclofenac—Nausea—Epirubicin—liver cancer	4.48e-05	0.000382	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—liver cancer	4.44e-05	0.000379	CcSEcCtD
Diclofenac—Rash—Doxorubicin—liver cancer	4.4e-05	0.000375	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—liver cancer	4.4e-05	0.000375	CcSEcCtD
Diclofenac—Headache—Doxorubicin—liver cancer	4.38e-05	0.000373	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—liver cancer	4.15e-05	0.000354	CcSEcCtD
Diclofenac—ABCC1—Disease—CDKN1B—liver cancer	3.61e-06	2.86e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A1—liver cancer	3.6e-06	2.86e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—liver cancer	3.59e-06	2.85e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.58e-06	2.85e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTM1—liver cancer	3.58e-06	2.84e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1A—liver cancer	3.57e-06	2.84e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP2E1—liver cancer	3.55e-06	2.82e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CG—liver cancer	3.55e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GOT2—liver cancer	3.53e-06	2.8e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.53e-06	2.8e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTA2—liver cancer	3.52e-06	2.8e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK8—liver cancer	3.49e-06	2.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HPGDS—liver cancer	3.48e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—liver cancer	3.48e-06	2.76e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—liver cancer	3.47e-06	2.75e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A1—liver cancer	3.46e-06	2.75e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.46e-06	2.75e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—liver cancer	3.43e-06	2.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—liver cancer	3.41e-06	2.71e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYCS—liver cancer	3.41e-06	2.7e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTA1—liver cancer	3.4e-06	2.7e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A1—liver cancer	3.39e-06	2.69e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—liver cancer	3.37e-06	2.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—liver cancer	3.37e-06	2.67e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—liver cancer	3.37e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—liver cancer	3.36e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NAT2—liver cancer	3.36e-06	2.67e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTHFR—liver cancer	3.36e-06	2.67e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.35e-06	2.66e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—liver cancer	3.34e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GOT1—liver cancer	3.34e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GGT1—liver cancer	3.34e-06	2.65e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CB—liver cancer	3.34e-06	2.65e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1A—liver cancer	3.33e-06	2.64e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYCS—liver cancer	3.32e-06	2.64e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—liver cancer	3.32e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP2E1—liver cancer	3.32e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—HMOX1—liver cancer	3.32e-06	2.63e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—HMOX1—liver cancer	3.3e-06	2.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARA—liver cancer	3.29e-06	2.61e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GGT1—liver cancer	3.26e-06	2.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GOT1—liver cancer	3.26e-06	2.59e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTHFR—liver cancer	3.23e-06	2.56e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALDOB—liver cancer	3.22e-06	2.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CB—liver cancer	3.22e-06	2.56e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—liver cancer	3.22e-06	2.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.21e-06	2.55e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—liver cancer	3.19e-06	2.53e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—liver cancer	3.17e-06	2.51e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARA—liver cancer	3.17e-06	2.51e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTHFR—liver cancer	3.16e-06	2.51e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.15e-06	2.5e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—liver cancer	3.13e-06	2.48e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CD—liver cancer	3.12e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.11e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYCS—liver cancer	3.11e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PSMA4—liver cancer	3.1e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PSMD10—liver cancer	3.1e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARA—liver cancer	3.1e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—liver cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—liver cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—liver cancer	3.08e-06	2.45e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—liver cancer	3.07e-06	2.44e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CRABP1—liver cancer	3.07e-06	2.44e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—liver cancer	3.06e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GGT1—liver cancer	3.05e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GOT1—liver cancer	3.05e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GOT2—liver cancer	3.02e-06	2.39e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—liver cancer	3e-06	2.38e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—liver cancer	2.98e-06	2.37e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—liver cancer	2.97e-06	2.36e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—liver cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—liver cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—HMOX1—liver cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—liver cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—liver cancer	2.93e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A1—liver cancer	2.93e-06	2.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—liver cancer	2.93e-06	2.32e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARA—liver cancer	2.92e-06	2.32e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A1—liver cancer	2.91e-06	2.31e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—HMOX1—liver cancer	2.89e-06	2.29e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—liver cancer	2.86e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP2E1—liver cancer	2.84e-06	2.25e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—liver cancer	2.82e-06	2.24e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—liver cancer	2.76e-06	2.19e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—liver cancer	2.76e-06	2.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—liver cancer	2.76e-06	2.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.75e-06	2.18e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—liver cancer	2.74e-06	2.17e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—liver cancer	2.74e-06	2.17e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—liver cancer	2.73e-06	2.17e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—liver cancer	2.72e-06	2.16e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—liver cancer	2.72e-06	2.16e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—liver cancer	2.72e-06	2.16e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—liver cancer	2.71e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HMOX1—liver cancer	2.7e-06	2.14e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—liver cancer	2.69e-06	2.14e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HPGDS—liver cancer	2.69e-06	2.13e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARA—liver cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARA—liver cancer	2.66e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—liver cancer	2.66e-06	2.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYCS—liver cancer	2.65e-06	2.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—liver cancer	2.64e-06	2.1e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—liver cancer	2.63e-06	2.09e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.63e-06	2.08e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—liver cancer	2.62e-06	2.08e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—liver cancer	2.62e-06	2.08e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GOT1—liver cancer	2.6e-06	2.07e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GGT1—liver cancer	2.6e-06	2.07e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—liver cancer	2.58e-06	2.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—liver cancer	2.58e-06	2.05e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—liver cancer	2.58e-06	2.04e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—liver cancer	2.56e-06	2.03e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—liver cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—liver cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—liver cancer	2.54e-06	2.02e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—liver cancer	2.52e-06	2e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—liver cancer	2.52e-06	2e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—liver cancer	2.51e-06	1.99e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—liver cancer	2.5e-06	1.99e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—liver cancer	2.48e-06	1.97e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—liver cancer	2.45e-06	1.94e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—liver cancer	2.44e-06	1.94e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—liver cancer	2.43e-06	1.93e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—liver cancer	2.43e-06	1.93e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—liver cancer	2.42e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—liver cancer	2.42e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.41e-06	1.91e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PSMA4—liver cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PSMD10—liver cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARA—liver cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—liver cancer	2.39e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—liver cancer	2.38e-06	1.89e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—liver cancer	2.38e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—liver cancer	2.35e-06	1.87e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—liver cancer	2.34e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—liver cancer	2.34e-06	1.86e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARA—liver cancer	2.34e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—liver cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GOT2—liver cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—liver cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMOX1—liver cancer	2.31e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—liver cancer	2.3e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—liver cancer	2.3e-06	1.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—liver cancer	2.29e-06	1.82e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—liver cancer	2.28e-06	1.81e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—liver cancer	2.24e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—liver cancer	2.23e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—liver cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—liver cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—liver cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—liver cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2E1—liver cancer	2.19e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARA—liver cancer	2.18e-06	1.73e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—liver cancer	2.17e-06	1.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—liver cancer	2.17e-06	1.72e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—liver cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—liver cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—liver cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—liver cancer	2.1e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—liver cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—liver cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—liver cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—liver cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYCS—liver cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—liver cancer	2.05e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—liver cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—liver cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—liver cancer	2.03e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—liver cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GGT1—liver cancer	2.01e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GOT1—liver cancer	2.01e-06	1.6e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—liver cancer	2.01e-06	1.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—liver cancer	2e-06	1.59e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—liver cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—liver cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—liver cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—liver cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—liver cancer	1.93e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—liver cancer	1.92e-06	1.52e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—liver cancer	1.92e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—liver cancer	1.9e-06	1.51e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—liver cancer	1.87e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARA—liver cancer	1.86e-06	1.48e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—liver cancer	1.85e-06	1.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—liver cancer	1.85e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—liver cancer	1.81e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—liver cancer	1.8e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—liver cancer	1.8e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMOX1—liver cancer	1.78e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—liver cancer	1.78e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—liver cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—liver cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—liver cancer	1.75e-06	1.39e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—liver cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—liver cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.67e-06	1.33e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—liver cancer	1.66e-06	1.32e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—liver cancer	1.66e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—liver cancer	1.66e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—liver cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—liver cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—liver cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—liver cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—liver cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—liver cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—liver cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—liver cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—liver cancer	1.53e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—liver cancer	1.47e-06	1.16e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—liver cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARA—liver cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—liver cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—liver cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—liver cancer	1.39e-06	1.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—liver cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—liver cancer	1.36e-06	1.08e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—liver cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—liver cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—liver cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—liver cancer	1.24e-06	9.85e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—liver cancer	1.23e-06	9.78e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—liver cancer	1.22e-06	9.71e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—liver cancer	1.19e-06	9.44e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—liver cancer	1.17e-06	9.28e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—liver cancer	1.08e-06	8.6e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—liver cancer	1.08e-06	8.54e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—liver cancer	1.07e-06	8.51e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—liver cancer	1.07e-06	8.49e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—liver cancer	1.07e-06	8.46e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—liver cancer	1.03e-06	8.21e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—liver cancer	1.01e-06	8.04e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—liver cancer	9.57e-07	7.6e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—liver cancer	9.55e-07	7.58e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—liver cancer	9.44e-07	7.49e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—liver cancer	9.34e-07	7.41e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—liver cancer	8.76e-07	6.95e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—liver cancer	8.73e-07	6.93e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—liver cancer	8.71e-07	6.91e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—liver cancer	7.82e-07	6.21e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—liver cancer	7.63e-07	6.06e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—liver cancer	7.46e-07	5.92e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—liver cancer	7.13e-07	5.66e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—liver cancer	6.09e-07	4.84e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—liver cancer	5.75e-07	4.57e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—liver cancer	4.7e-07	3.73e-06	CbGpPWpGaD
